These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39212374)

  • 21. [The best of valvular heart disease in 2006].
    de Gevigney G;
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of selective serotonin reuptake inhibitor therapy on heart valves in patients exposed to benfluorex: a multicentre study.
    Maréchaux S; Jeu A; Jobic Y; Ederhy S; Donal E; Réant P; Abouth S; Arnasteen E; Boulanger J; Ennezat PV; Garban T; Szymanski C; Tribouilloy C
    Arch Cardiovasc Dis; 2013; 106(6-7):349-56. PubMed ID: 23876809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
    Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
    Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Profiles of hospitalized patients with valvular heart disease: Experience of a tertiary center.
    Esteves AF; Brito D; Rigueira J; Ricardo I; Pires R; Pedro MM; Veiga F; Pinto F
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):991-998. PubMed ID: 30554887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and correlates of valvular heart diseases in the elderly population in Hubei, China.
    Shu C; Chen S; Qin T; Fu Z; Sun T; Xie M; Zhang L; Dong N; Yin P
    Sci Rep; 2016 Jun; 6():27253. PubMed ID: 27250873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiologic Profile of Patients With Valvular Heart Disease in Korea: A Nationwide Hospital-Based Registry Study.
    Choi YJ; Son JW; Kim EK; Kim IC; Kim HY; Seo JS; Sun BJ; Shim CY; Yoon SJ; Lee S; Lee SH; Park JB; Kang DH
    J Cardiovasc Imaging; 2023 Jan; 31(1):51-61. PubMed ID: 36693346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valvular Heart Disease in Adults: Management of Native Valve Disease.
    Zhang X; Hollenberg SM
    FP Essent; 2017 Jun; 457():17-22. PubMed ID: 28671805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology Guidelines for the Management of Patients With Valvular Heart Disease.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Sorajja P; Gössl M; Garcia S; Jneid H; Kakouros N; Martinez-Parachini JR; Resendes E; Kalsaria P; Roesle M; Rangan BV; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2017 Sep; 29(9):320-326. PubMed ID: 28420803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis.
    Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H
    Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Mitral and Aortic Valvular Disease and Left Ventricular Dysfunction in a Lebanese Population: Retrospective Single-Center Experience.
    Nader V; Matta A; Canitrot R; Itier R; Salameh P; Lairez O; Elbaz M; Galinier M; Azar R; Roncalli J
    Med Sci Monit; 2021 Feb; 27():e928218. PubMed ID: 33558450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience.
    Manjunath CN; Srinivas P; Ravindranath KS; Dhanalakshmi C
    Indian Heart J; 2014; 66(3):320-6. PubMed ID: 24973838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Vinereanu D; Wang A; Mulder H; Lopes RD; Jansky P; Lewis BS; Gersh BJ; Avezum A; Hanna M; Held C; Wallentin L; Granger CB; Alexander JH
    Heart; 2018 Aug; 104(15):1292-1299. PubMed ID: 29352007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac valvular surgery and history of anorectic drug intake: A retrospective study of a large population of benfluorex-exposed patients.
    Laurent M; Ennezat PV; Malergue MC; Bruneval P;
    Arch Cardiovasc Dis; 2022; 115(6-7):348-358. PubMed ID: 35697655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Shelbaya K; Claggett B; Dorbala P; Skali H; Solomon SD; Matsushita K; Konety S; Mosley TH; Shah AM
    Circulation; 2023 Feb; 147(8):638-649. PubMed ID: 36524478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the Recent Updates to the ACC/AHA and ESC Guidelines for the Management of Valvular Heart Disease: Similarities and Differences.
    Laskar N; Badiani S; Treibel T; Bhattacharyya S; Lloyd G
    Curr Cardiol Rep; 2023 Mar; 25(3):147-156. PubMed ID: 36708504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tricuspid regurgitation in the context of severe left-sided valvular disease: Patients characteristics and outcome.
    Margonato D; Ingallina G; Belli M; Tavernese A; Ricchetti G; Ancona F; Stella S; Biondi F; Fiore G; De Bonis M; Maisano F; Topilsky Y; Agricola E
    Heliyon; 2024 Jul; 10(14):e34874. PubMed ID: 39148991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank.
    Tung M; Nah G; Tang J; Marcus G; Delling FN
    Open Heart; 2022 Sep; 9(2):. PubMed ID: 36104095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive Nursing Management for Valvular Disease.
    Lee S
    Crit Care Nurs Clin North Am; 2019 Mar; 31(1):31-38. PubMed ID: 30736933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and Prognosis of Patients With Nonvalvular Atrial Fibrillation and Significant Valvular Heart Disease Referred for Electrical Cardioversion.
    Vo NM; Leung M; van Rosendael PJ; Goedemans L; van Wijngaarden SE; Prihadi EA; van der Bijl P; Ajmone Marsan N; Delgado V; Bax JJ
    Am J Cardiol; 2020 Aug; 128():84-91. PubMed ID: 32650929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary Management of Severe Symptomatic Aortic Stenosis.
    Eugène M; Duchnowski P; Prendergast B; Wendler O; Laroche C; Monin JL; Jobic Y; Popescu BA; Bax JJ; Vahanian A; Iung B;
    J Am Coll Cardiol; 2021 Nov; 78(22):2131-2143. PubMed ID: 34823655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.